Cargando…
Direct-acting Anticoagulants in Chronic Coronary Syndromes
Direct-acting oral anticoagulants (DOACs) are easier to use, safer than and as effective as vitamin K antagonists (VKA) in the treatment of non-valvular AF (NVAF). Because of their favourable safety profile and easier use than VKAs, DOACs as anti-thrombotic therapy may have a role in the management...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radcliffe Cardiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066807/ https://www.ncbi.nlm.nih.gov/pubmed/32180831 http://dx.doi.org/10.15420/ecr.2018.24.2 |